VRTX vs ZWS · P/E 30, rev $3.33B vs P/E 47, rev $1.70B
Vertex Pharmaceuticals Inc (VRTX) versus Zurn Elkay Water Solutions Corporation (ZWS) — a side-by-side from cached financials, not a winner call.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Zurn Elkay Water Solutions Corporation (ZWS) is a pollution & treatment controls company listed on US.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Latest reported ZWS revenue for 2025-12-31 was $1.70B. Net income was $198.0M. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. ZWS currently screens at market cap $7.87B and trailing P/E 47.4.
VRTX currently screens at market cap $106.87B and trailing P/E 29.7. ZWS currently screens at market cap $7.87B and trailing P/E 47.4.
Not investment advice. Open the VRTX and ZWS stock pages for the full models.
Not investment advice.